映恩生物-B(09606.HK)8月26日举行董事会会议考虑及批准中期业绩
Group 1 - The company, InnoCare Pharma Limited (映恩生物-B), will hold a board meeting on August 26, 2025, to consider and approve its unaudited interim results for the six months ending June 30, 2025 [1]
Group 1 - The company, InnoCare Pharma Limited (映恩生物-B), will hold a board meeting on August 26, 2025, to consider and approve its unaudited interim results for the six months ending June 30, 2025 [1]